Cargando…

Possible Association of Multicentric Castleman's Disease with Autoimmune Lymphoproliferative Syndrome

Multicentric Castleman's disease (MCD) is lymphoproliferative disorder characterized by systemic inflammatory symptoms such as fever and weight loss. Human herpes virus-8 (HHV-8) is thought to be a causable pathogen in all HIV-positive and some HIV-negative MCD patients. Furthermore, the term i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minemura, Hiroyuki, Tanino, Yoshinori, Ikeda, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2018
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908426/ https://www.ncbi.nlm.nih.gov/pubmed/29682404 http://dx.doi.org/10.1089/biores.2017.0025

Ejemplares similares

Castleman disease and mimickers: Clinicopathological findings of atypical lymphoproliferative disorders associated with autoimmune disease
por: Nakazato, Yoshimasa, et al.
Publicado: (2022)

A Rare Lymphoproliferative Disease: Castleman Disease
por: Gündüz, Eren, et al.
Publicado: (2021)

Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis
por: González García, Andrés, et al.
Publicado: (2022)

Multicentric Castleman disease and the evolution of the concept
por: Zhou, Ting, et al.
Publicado: (2021)

Multicentric Castleman disease with TAFRO syndrome and Sjögren's
por: Li, Zi Ying, et al.
Publicado: (2019)

HIV-associated multicentric Castleman's disease
por: Naime, Fauzia de Fátima, et al.
Publicado: (2012)

Updates on the diagnosis and management of multicentric Castleman disease
por: Wu, Ya-Ju, et al.
Publicado: (2020)

Candidate biomarkers for idiopathic multicentric Castleman disease
por: Sumiyoshi, Remi, et al.
Publicado: (2022)

Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
por: Nishimura, Yoshito, et al.
Publicado: (2022)

Autoimmune lymphoproliferative syndrome: more than a FAScinating disease
por: Bride, Karen, et al.
Publicado: (2017)

Multicentric Castleman's Disease, Associated with Idiopathic Thrombocytopenic Purpura
por: Sood, Ruchi, et al.
Publicado: (2013)

Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease
por: Sitenga, Jenna, et al.
Publicado: (2018)

A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease
por: Butzmann, Alexandra, et al.
Publicado: (2021)

Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes
por: Gámez-Díaz, Laura, et al.
Publicado: (2021)

Multicentric Castleman's disease: Report of three cases
por: Guazzaroni, M., et al.
Publicado: (2018)

Multicentric Castleman's disease: a case report
por: Menezes, Brian F, et al.
Publicado: (2007)

Multicentric Castleman disease with infiltration of eosinophils to the lung
por: Nakai, Shogo, et al.
Publicado: (2021)

Alveolar Hemorrhage in Idiopathic Multicentric Castleman’s Disease
por: Huang, Lingtong, et al.
Publicado: (2023)

Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan
por: Masaki, Yasufumi, et al.
Publicado: (2019)

A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome
por: Ük, Ece, et al.
Publicado: (2022)

Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi
por: Gopal, Satish, et al.
Publicado: (2015)

Castleman disease, TAFRO syndrome, idiopathic plasmacytic lymphadenopathy, and autoimmune disease
por: Nakamura, Naoya
Publicado: (2022)

Diffuse cryptococcal pneumonia in multicentric Castleman’s disease with elevated serum IgG(4)
por: Takiguchi, Junji, et al.
Publicado: (2023)

Castleman disease and TAFRO syndrome
por: Masaki, Yasufumi, et al.
Publicado: (2022)

Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
por: Tabata, Sakiko, et al.
Publicado: (2019)

Castleman's Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
por: Jha, Lokesh K., et al.
Publicado: (2018)

Chronic Myelomonocytic Leukemia following Multicentric Castleman Disease
por: Li, Feng, et al.
Publicado: (2018)

Irreversible Kidney Damage due to Multicentric Castleman's Disease
por: Kahn, Fredrik, et al.
Publicado: (2008)

Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma
por: Yaghoobi, Reza, et al.
Publicado: (2015)

Idiopathic Multicentric Hyaline Vascular-Type Castleman Disease
por: Moutinho, Adelaide, et al.
Publicado: (2021)

Different Types of Skin Lesions in Multicentric Castleman Disease
por: Nakamura, Yoshihiro, et al.
Publicado: (2022)

Multicentric Castleman Disease of the Supraglottis: A Surgeons’ Dilemma
por: Jumaat, Anna Fariza, et al.
Publicado: (2023)

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease
por: Arakawa, Akira, et al.
Publicado: (2021)

Interstitial Lung Disease Is a Possible Manifestation of Anti-signal Recognition Particle Antibody Syndrome
por: Tanino, Yoshinori
Publicado: (2018)

Getting Under the Skin: Targeting Cutaneous Autoimmune Disease
por: Vesely, Matthew D.
Publicado: (2020)

Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases
por: Ryan, Brent J., et al.
Publicado: (2014)

Disturbed B-lymphocytes selection in autoimmune lymphoproliferative syndrome
por: Janda, Aleš, et al.
Publicado: (2015)

Unexplained lymphadenopathies: autoimmune lymphoproliferative syndrome in an adult patient
por: Leal-Seabra, Fatima, et al.
Publicado: (2016)

Autoimmune lymphoproliferative syndrome identified through reverse phenotyping
por: Kocheva, Svetlana, et al.
Publicado: (2022)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_um4oscad2qtuhl7hanjgb6jf4b